Advertisement

First Edition

December 10, 2018

December 07, 2018

December 06, 2018

  • The multifaceted role of fibrinogen in tissue injury and inflammation
    James P. Luyendyk, Jonathan G. Schoenecker and Matthew J. Flick
  • Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study
    Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chavez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak and Steven P. Treon

December 04, 2018

December 03, 2018

December 01, 2018

November 29, 2018

November 28, 2018

November 27, 2018

November 26, 2018

November 21, 2018

  • GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
    Rosalie M. Sterner, Reona Sakemura, Michelle J. Cox, Nan Yang, Roman H. Khadka, Cynthia L. Forsman, Michael J. Hansen, Fang Jin, Katayoun Ayasoufi, Mehrdad Hefazi, Kendall J. Schick, Denise K. Walters, Omar Ahmed, Dale Chappell, Tarek Sahmoud, Cameron Durrant, Wendy K. Nevala, Mrinal M. Patnaik, Larry Pease, Karen E. Hedin, Neil E. Kay, Aaron J. Johnson and Saad S. Kenderian

November 20, 2018

  • How I treat infant leukemia
    Patrick Brown, Rob Pieters and Andrea Biondi

November 19, 2018

  • IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
    Elisa Bergaggio, Chiara Riganti, Giulia Garaffo, Nicoletta Vitale, Elisabetta Mereu, Cecilia Bandini, Elisa Pellegrino, Verdiana Pullano, Paola Omedè, Katia Todoerti, Luciano Cascione, Valentina Audrito, Anna Riccio, Antonio Rossi, Francesco Bertoni, Silvia Deaglio, Antonino Neri, Antonio Palumbo and Roberto Piva
  • Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab
    Anton W. Langerak, Matthias Ritgen, Valentin Goede, Sandra Robrecht, Jasmin Bahlo, Kirsten Fischer, Michael Steurer, Marek Trněný, Stephen P. Mulligan, Ulrich J.M. Mey, Kerstin Trunzer, Günter Fingerle-Rowson, Kathryn Humphrey, Stephan Stilgenbauer, Sebastian Böttcher, Monika Brüggemann, Michael Hallek, Michael Kneba and Jacques J.M. van Dongen

November 16, 2018

  • The genomic landscape of plasma cells in systemic light chain amyloidosis
    Eileen M. Boyle, Cody Ashby, Christopher P. Wardell, Dorota Rowczenio, Sajitha Sachchithanantham, Yan Wang, Sarah K. Johnson, Michael A. Bauer, Niels Weinhold, Martin F. Kaiser, David C. Johnson, John R. Jones, Charlotte Pawlyn, Paula Proszek, Carolina Schinke, Thierry Facon, Charles Dumontet, Faith E. Davies, Gareth J. Morgan, Brian A. Walker and Ashutosh D. Wechalekar
  • Genomic alterations important for the prognosis in patients with follicular lymphoma treated on SWOG study S0016
    Xiaoyu Qu, Hongli Li, Rita M. Braziel, Verena Passerini, Lisa M. Rimsza, Eric D. Hsi, John P. Leonard, Sonali M. Smith, Robert Kridel, Oliver Press, Oliver Weigert, Michael LeBlanc, Jonathan W. Friedberg and Min Fang
  • Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
    Jessica L. Brady, Michael S. Binkley, Carla Hajj, Monica Chelius, Karen Chau, Alex Balogh, Mario Levis, Andrea Riccardo Filippi, Michael Jones, Michael Mac Manus, Andrew Wirth, Masahiko Oguchi, Anders Krog Vistisen, Therese Youssef Andraos, Andrea K. Ng, Berthe M.P. Aleman, Seo Hee Choi, Youlia Kirova, Sara Hardy, Gabriele Reinartz, Hans T. Eich, Scott V. Bratman, Louis S. Constine, Chang-Ok Suh, Bouthaina Dabaja, Tarec C. El-Galaly, David C. Hodgson, Umberto Ricardi, Joachim Yahalom, Richard T. Hoppe and N. George Mikhaeel

November 15, 2018

November 14, 2018

November 13, 2018

November 09, 2018

Pages